View text source at Wikipedia
This article needs additional citations for verification. Please help improve this article by adding citations to reliable sources. Unsourced material may be challenged and removed. Find sources: "Guacetisal" – news · newspapers · books · scholar · JSTOR (November 2023) (Learn how and when to remove this message) |
Clinical data | |
---|---|
Trade names | Broncaspin; Balsacetil; Guaiaspir; Prontomucil |
Other names | Aspirin guaiacol ester; O-Methoxyphenyl salicylate acetate |
ATC code | |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
ChemSpider | |
UNII | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.054.221 |
Chemical and physical data | |
Formula | C16H14O5 |
Molar mass | 286.283 g·mol−1 |
3D model (JSmol) | |
Melting point | 72 to 74.5 °C (161.6 to 166.1 °F) |
| |
|
Guacetisal is a drug that has been used to treat inflammatory respiratory diseases.[1] Chemically, it is an ester resulting from the combination of aspirin and guaiacol.[citation needed]
pyrazolones / pyrazolidines | |
---|---|
salicylates | |
acetic acid derivatives and related substances | |
oxicams | |
propionic acid derivatives (profens) |
|
n-arylanthranilic acids (fenamates) | |
COX-2 inhibitors (coxibs) | |
other | |
NSAID combinations | |
Key: underline indicates initially developed first-in-class compound of specific group; #WHO-Essential Medicines; †withdrawn drugs; ‡veterinary use. | |
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |